Anastasios Bastounis
Overview
Explore the profile of Anastasios Bastounis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambers D, Baxter S, Bastounis A, Jones K, Kundakci B, Cantrell A, et al.
Health Technol Assess
. 2025 Mar;
:1-53.
PMID: 40085432
Background: Population-wide newborn blood spot screening programmes are a successful public health intervention used to detect whether the baby is at risk of certain rare conditions, with the aim of...
2.
Tran P, Kwon J, Bastounis A, Petrou S, Booth A
F1000Res
. 2025 Feb;
13:1382.
PMID: 40018300
Systematic reviews of health economic evaluations play a crucial role in informing evidence-based healthcare decisions, yet they lack standardized reporting guidelines. A project has been initiated that aims to extend...
3.
Efthymiadis A, Bastounis A, Liu L, Bourlaki M, Spinos D, Tsikopoulos K
J Diabetes Metab Disord
. 2024 Nov;
23(2):2251-2261.
PMID: 39610490
Objectives: Impaired awareness of hyperglycaemia (IAH) affects approximately 20-40% of people living with type 1 diabetes (T1D), predisposing them to severe hypoglycaemia. This systematic review evaluated the efficacy of closed-loop...
4.
Carroll C, Kundakci B, Muhinyi A, Bastounis A, Jones K, Sutton A, et al.
BMJ Open Qual
. 2024 Sep;
13(3).
PMID: 39299774
Introduction: Prolonged ambulance response times and unacceptable emergency department (ED) wait times are significant challenges in urgent and emergency care systems associated with patient harm. This scoping review aimed to...
5.
Sahota O, Narayanasamy M, Bastounis A, Paskins Z, Bishop S, Langley T, et al.
Health Technol Assess
. 2024 Apr;
28(21):1-169.
PMID: 38634483
Background: Bisphosphonates are a class of medication commonly used to treat osteoporosis. Alendronate is recommended as the first-line treatment; however, long-term adherence (both treatment compliance and persistence) is poor. Alternative...
6.
Wieland S, Melton S, Bastounis A, Carter T
Behav Cogn Psychother
. 2024 Feb;
52(4):394-413.
PMID: 38389281
Background: Depression is a common co-morbidity in women with breast cancer. Previous systematic reviews investigating cognitive behavioural therapy (CBT) for depression in this population based their conclusions on findings from...
7.
Efthymiadis A, Henry M, Spinos D, Bourlaki M, Tsikopoulos A, Bourazana A, et al.
Clin Endocrinol (Oxf)
. 2023 Dec;
100(5):488-501.
PMID: 38037493
Objective: Thyroid hormone under-replacement and over-replacement are associated with adverse health outcomes. This systematic review aimed to evaluate the extent of thyroid hormone replacement adequacy for patients with known hypothyroidism...
8.
Bishop S, Narayanasamy M, Paskins Z, Corp N, Bastounis A, Griffin J, et al.
BMC Musculoskelet Disord
. 2023 Sep;
24(1):770.
PMID: 37770860
Background: Bisphosphonate medications, including alendronate, ibandronate and risedronate administered orally and zoledronate, administered intravenously, are commonly prescribed for the treatment of osteoporosis based on evidence that, correctly taken, bisphosphonates can...
9.
Paskins Z, Moult A, Corp N, Bastounis A, Davis S, Narayanasamy M, et al.
Osteoporos Int
. 2023 Jun;
34(10):1711-1718.
PMID: 37294333
Purpose: Worldwide, many people who would benefit from osteoporosis drugs are not offered or receiving them, resulting in an osteoporosis care gap. Adherence with bisphosphonates is particularly low. This study...
10.
Hartmann-Boyce J, Theodoulou A, Oke J, Butler A, Bastounis A, Dunnigan A, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Mar;
16(4):e009348.
PMID: 36974678
Background: Behavioral weight management programs (BWMPs) enhance weight loss in the short term, but longer term cardiometabolic effects are uncertain as weight is commonly regained. We assessed the impact of...